Related by context. All words. (Click for frequent words.) 65 Marketing Authorisation 65 Marketing Authorization Applications 64 Mutual Recognition Procedure 63 Marketing Authorization 62 Orphan Drug designations 62 Marketing Authorisations 62 Tostrex 61 rolling Biologics License 61 Decentralized Procedure 61 Loramyc ™ 60 Centralized Procedure 60 Alvesco ® 60 Marketing Authorisation Application 59 Loramyc R 59 GMP Certification 59 EDQM 59 OMP designation 59 Amlodipine Besylate Tablets 59 orphan designation 59 Authorisations 59 Raptiva R 59 Oracea ® 59 Marketing Authorisation Application MAA 59 Expedited Review 58 Orphan Drug status 58 Loramyc TM 58 Orphan Drug designation 58 Metoprolol Succinate 58 SCHWARZ PHARMA 58 Emezine 58 SYCREST 57 Orphan Drug Status 57 Fast Track designations 57 Loramyc ® 57 Biologic License Application BLA 57 CIP TRAMADOL ER 57 MAA submission 57 Fast Track Status 56 MEZAVANT 56 Sensipar R 56 Certican 56 GRAS notification 56 Increlex TM 56 ULTRASE 56 ZEFTERA ™ 56 Orphan Designation 56 Act PDUFA date 56 Alvesco R 56 Targretin capsules 56 Marketing Authorization Application 56 Plenaxis R 56 Biological License Application 56 Zebinix R 56 SEASONALE R 56 No Objection Letter 56 FACTIVE tablets 56 IND Investigational New 55 Mimpara 55 Pliaglis 55 Raptiva ® 55 CoPP 55 Angiox 55 liver resection surgeries 55 subsidiaries visit http:/www.apricusbio.com 55 FIRAZYR 55 CAMPATH R 55 BRILINTA 55 Thalidomide Pharmion 55 Drug Submission 55 pediatric exclusivity 55 TRISENOX ® 55 SmPC 55 Accelerated Assessment 55 THELIN 55 Receives Marketing Authorization 55 Eloxatin ® 55 Application MAA 55 Cellegesic 55 IPM Wound Gel 55 Sanvar R 55 Declares Dividend Quick Facts 55 Preotact 55 SWX SPPN 55 Sunesis Pharma 55 ANVISA 55 Somatuline R Autogel R 55 SoftM AG 55 Accelerated Approval 55 udenafil 55 Trobalt 55 k Premarket Notification 55 Material Fact 55 ANDAs pending approval 55 CONBRIZA 55 Hexvix ® 55 Toctino R 55 HalcyGen 55 Lovaza TM 54 Marketing Authorization Application MAA 54 Firdapse 54 InterfeRx 54 No. #.# 54 Esbriet pirfenidone 54 Adenuric R 54 GTC recombinant form 54 Solasia 54 Premarket Approval 54 Orphan Status 54 Rectogesic 54 TheraCIM 54 Toctino ® 54 Fortical ® 54 FDA Approvable Letter 54 orphan medicinal 54 RCEs 54 Angiox ® 54 NESINA 54 WHO prequalification 54 Increlex R 54 Olerup SSP 54 Preotact R 54 Complete Response 54 balsalazide tablet 54 MTVO 54 CHMP recommendation 54 ATryn ® 54 TGZ 54 SNT MC# 54 ADDERALL XR R 54 MHLW 54 Submits Response 54 Esbriet ® 54 NIPs 54 BioTie 54 LECTRA 54 OTC ZEGERID 54 iChem VELOCITY 54 Urocidin TM 54 Sumatriptan Succinate 54 Nabi HB R 54 ENTOCORT EC 54 Basilea Toctino R 54 rapid prototyping patents 54 GRAS Status 54 USFDA approval 54 Master File DMF 54 Paragraph IV 54 ANDA submission 54 HNTE 54 Gestiva TM 54 Abstral ® 54 Æterna Zentaris 54 Common Criteria Recognition 53 Aflunov 53 GLASSIA ™ 53 LUCENTIS r 53 Decentralized Procedure DCP 53 PIPE Financing 53 PTI SJY 53 TRISENOX 53 Salcomp Plc 53 discloseable transaction 53 ANDAs pending 53 Oncoscience AG 53 SEBIVO 53 Erythropoiesis Stimulating Agents ESAs 53 DC Bead 53 CLIA waiver 53 CA# [005] 53 Orphan designation 53 Inovio AS 53 Evoltra ® 53 PLAVIX ® 53 miconazole Lauriad ® 53 Yondelis ® 53 Premarket Approval Application 53 Complete Response letter 53 buccal spray 53 Fanapt ® 53 GTC recombinant human 53 Monovisc TM 53 Nivestim 53 vinorelbine emulsion 53 Aloxi Injection 53 euro adhoc Intercell AG 53 Sublicense Agreement 53 Dacogen TM 53 Akorn Strides 53 OAO WGC 5 53 Alitretinoin 53 Investigational Device Exemption 53 PDOs 53 Japanese Encephalitis Vaccine 53 THALOMID 53 eprodisate KIACTA TM 53 Specified Investment 53 Zirgan 53 Ciclesonide 53 Kyowa Kirin 53 Oravig ® 53 CORTOSS Bone Augmentation Material 53 EFFECTIVE DATE 53 Clindesse TM 53 Commercialization Agreement 53 Nippon Shinyaku 53 Aldara ® 53 elexis AG 53 SOLODYN 53 premerger notification 53 Febuxostat 53 CE Marked 53 Gentamicin Surgical Implant 53 cusip number 53 Pharmacopoeia USP 53 VCRT 53 please visit www.advaxis.com 53 ORTHOVISC mini 53 MDGC 53 Methylphenidate Transdermal System 53 vapreotide acetate 52 Sanochemia Pharmazeutika AG 52 Glufast 52 Tracleer r 52 TEMODAL 52 Graphic Packaging Corporation 52 IV acetaminophen 52 Abbotly 52 decree № 52 Announces Tentative Approval 52 TMSH 52 Reexamination Certificate 52 Drug Submission NDS 52 NLTX 52 PMPRB 52 lender consents 52 Granted Orphan Drug 52 CERVARIX R 52 patent EP# 52 Fortigel 52 OPENLiMiT Holding AG 52 miconazole Lauriad R 52 elbion GmbH 52 Splendid Medien AG 52 MoxDuo IR 52 CAGE Code 52 Exploitation Concession 52 Auxilium Pharma 52 PGL# 52 Incentive Warrants 52 Notified Bodies 52 recombinant FVIII 52 y Ambiente SERNA Honduras 52 License Application 52 Zenpep 52 OPENLiMiT 52 Adenuric ® 52 Submits NDA 52 desvenlafaxine 52 Vascular Wrap TM 52 MOVIPREP R 52 XAGRID 52 RELISTOR ® 52 Notified Body 52 Georox Resources Inc. 52 LUCASSIN 52 AIMMS 52 Topiramate Tablets 52 Dexo 52 AZOR TM 52 ColonSentry test 52 ChemBioPrint 52 RNRG 52 Firazyr 52 Subpart E 52 FDA Accelerated Approval 52 PPTI 52 IGXT IntelGenx today 52 HACCP certification 52 NASDAQ PGNX 52 BioDelivery Sciences 52 Zegerid OTC 52 Meda STO MEDAA 52 AMEX IVX LSE IVX.L 52 #.# [023] 52 Nitoman 52 #D#C# 52 Relieva 52 IAY houses 52 Metabasis stockholders 52 Frequency Allocation Plan 52 Office CIPO 52 PROVIGIL 52 Receives Approval From 52 generic atorvastatin 52 Risperidone Oral Solution 52 Scientific Advice 52 DMFs 52 FACTIVE R gemifloxacin 52 BioGeneriX 52 Substantial Issuer Bid 52 accredited registrar 52 Clinical Trial Application 52 Amitiza ® 52 Monovisc 52 RAPTIVA r 52 JunJing III 52 SURFAXIN 52 WILEX AG 52 nasal calcitonin product 52 FDA approvable letter 52 ATryn R 52 Disclosure Document 52 R bivalirudin 52 ErgoGroup AS 52 G#DT 52 PROMACTA ® 52 Biotie Therapies Corp. 52 gastrointestinal disorders ATI 52 Allovectin 7 r 52 Biovitrum AB publ 52 tramadol HCl 52 Files Investigational 52 Barr ANDA 52 miRNA therapeutics 52 Announcement acc 52 Operator Certificate AOC 52 Cefprozil 52 Marketing Approval PMA 52 PRIALT 52 Orphan Drug Designation 52 Fresenius Biotech 52 & LSE GLPG 52 Taiho Pharmaceutical 52 Kunekt Corporation 52 BEMA Fentanyl 52 Rotarix R 52 ANDA approvals 52 NYSE GGY 52 SFDA approval 52 telavancin NDA 52 Orphan Medicinal Product 52 Paris IPN 52 ISIN codes 52 SNPY 52 Betaseron ® 52 FOLOTYN ® 52 Seasonal Influenza Vaccine 52 Picchio Pharma 52 Nasdaq PGNX today 52 ZEGERID Capsules 52 Xenazine ® 52 Patent Covering 52 JV SpeBio 52 Patent Upheld 52 Secretaria de Recursos Naturales 52 OTCBB NPHC 51 IMMUNITY FX 51 upto #.#.# 51 CYNX 51 Glenmark Generics Limited 51 Dacogen injection 51 Fanapt ™ 51 Dermylex R 51 Fortical R 51 Shelf Registration Statement 51 USDOC 51 Veregen R 51 Applicant Guidebook 51 PDUFA Date 51 Lipofen 51 Receives NASDAQ 51 ALTANA AG NYSE 51 Glucophage XR 51 Loramyc 51 registrational studies 51 Market Authorization Application 51 pitavastatin 51 Australian Therapeutic Goods 51 Omacor ® 51 Orphan Drugs 51 Oncolys 51 PREOS R 51 AMEX RGN www.regenerx.com 51 PhotoCure 51 Argatroban 51 Approvable 51 BioGlue ® 51 Evoltra 51 Receives Orphan Drug 51 Doha Ministerial Declaration 51 Apricus Bio 51 CEII 51 Health Regulations IHR 51 Bendamustine 51 Max Neeman 51 LibiGel NDA 51 please visit www.innercool.com 51 Retacrit 51 Cintredekin besudotox 51 TSX VENTURE CZO 51 Cencorp 51 Flutiform TM 51 Circadin 51 Biologic License Application 51 Biologics License Application 51 Voraxaze 51 Rheoscience 51 RCUs 51 Orapred ODT 51 Stedesa 51 Nabi HB Intravenous 51 Synerx Pharma 51 Movectro 51 Etteplan Oyj 51 News Unternehmensnachrichten DGAP Adhoc 51 Serdolect ® 51 MEDIA LIMITED 51 ZBx 51 Intas Biopharmaceuticals 51 SOLODYN R 51 miconazole MBT 51 known teratogen substance 51 HuMax TAC 51 prasterone 51 galantamine hydrobromide 51 EACs 51 sNDAs 51 Pennsaid R 51 ZADAXIN ® 51 JOULFERON 51 Tekturna Rasilez 51 Periostat R 51 Pieris AG 51 Ganciclovir 51 RISDP 51 Applications ANDA 51 NasdaqGM SPPI 51 DOXIL R 51 Receives Orphan Drug Designation 51 InvaGen 51 PAION AG 51 sumatriptan injection 51 Operator Certificate 51 ISO #:# certifications [002] 51 explanatory memoranda 51 Envirokare 51 TSX SHQ 51 Pharnext 51 Combined License Application 51 acyclovir Lauriad R 51 jurisdictional thresholds 51 Milestone Payments 51 Stragen 51 ABHD 51 NEIIPP 51 EHT AGN 51 Juvantia 51 IVD CE 51 Drug Eluting Stent System 51 EDIG 51 Biologics License Applications 51 Vimpat ® lacosamide 51 STRIANT 51 Fast Track Designation 51 Multiferon R 51 CIP Fenofibrate 51 David Gower P.Geo 51 SEASONALE 51 BiDil XR 51 Clearance Certificate 51 Fludara ® 51 OTGI 51 prostone 51 rasagiline tablets 51 pixantrone NDA 51 Axentis Pharma 51 ISINs 51 CryoSeal 51 EGRIFTA 51 DATES Written comments 51 UVIDEM 51 essentiality certificate 51 methylphenidate HCl 51 REPLAGAL 51 QTDP Program 51 MacroChem Corporation 51 VYVANSE TM lisdexamfetamine 51 Drug Applications ANDAs 51 CRINONE 8 51 Stock Purchase Agreements 51 Etteplan 51 Somatuline R Depot 51 EAL4 + certification 51 ISO #:# Certification [001] 51 Premarket Notification 51 Valortim TM 51 Amending Directive 51 Decapeptyl R 51 UCB Pharma SA 51 Orexo 50 Medicinal Products EMEA 50 PIA SarGen top 50 Resubmission 50 RSU Plan 50 PrevOnco 50 Competent Authorities 50 Seikagaku Corporation 50 CFR #.# c 50 Biologics Licensing 50 PAIC 50 ChemGenex Pharmaceuticals Limited 50 DRIP Plan 50 Junovan TM 50 TWYNSTA ® 50 Lubiprostone 50 sublingual tablets 50 Ranolazine 50 Dyloject TM 50 assigned PDUFA 50 WHTI compliant documents 50 DIFICID ™ 50 PROVIGIL R 50 commercialize oritavancin 50 casopitant 50 ANDA filings 50 vancomycin hydrochloride 50 GLASSIA 50 Cinacalcet HCl 50 GeoVax AIDS vaccine 50 Vitaros 50 Entocort 50 Premarket Approval PMA 50 Gonal f 50 CryoSeal FS System 50 Veregen TM 50 Lexiscan TM 50 Galephar 50 website http:/www.npsp.com 50 submit Biologics License 50 Glycotex Inc. 50 Semperit AG Holding 50 BW Offshore Limited 50 Medicines Agency 50 Angiox R 50 orphan medicinal product 50 Submits Supplemental 50 AFSSAPS 50 Thelin TM 50 Qutenza TM 50 Transparency Directive 50 ASX PGL 50 Veregen ® 50 Triage Stroke Panel 50 Surfaxin lucinactant 50 FASTx TM 50 Synvisc ONE 50 Penwest Pharmaceuticals Co 50 Tender Documents 50 Biovitrum AB 50 CIMZIA r 50 wef 1st 50 visitorial 50 Lupin Pharmaceuticals Inc. 50 Kepivance 50 HSR clearance 50 RhuDex ® 50 AltaRex 50 Icatibant 50 SEDAR Filings 50 CE Marking 50 Zevtera ™ 50 BioDelivery Sciences Announces 50 tramiprosate ALZHEMED TM 50 WTO TRIPS Agreement 50 SEBI Guidelines 50 alvimopan 50 Product Characteristics 50 Proposed Arrangement 50 Aoxing Pharmaceutical Company 50 Sycrest 50 GMP Certificate 50 Euroclear Sweden 50 PGP Acquisition 50 ANDA abbreviated 50 BLA filing 50 EIS OEIS 50 Virulizin R 50 BLAs 50 TORs 50 Synerx 50 P#X# antagonist 50 Homeopathic Pharmacopoeia 50 ISTODAX 50 NeuroSolutions 50 BULLETIN TYPE Reinstated 50 FFDCA 50 Vitaros R 50 NASDAQ IPXL today 50 http:/www.repligen.com 50 ICSID arbitration 50 Registrar Accreditation 50 histamine dihydrochloride 50 AIPPI 50 QFB license 50 miniratna status 50 EASY SOFTWARE AG 50 Contingent Consideration 50 shares issuable thereunder 50 Civacir 50 telaprevir VX 50 Financing Agreements 50 FDA Complete Response 50 Vimpat R 50 Inc. OTCBB ALRX 50 hoFH 50 Section #AA [002] 50 Pennsaid Plus 50 Falk Pharma 50 DATES Comments 50 Venturepharm 50 Securite Sanitaire des Produits 50 AMITIZA lubiprostone 50 PRAECIS PHARMACEUTICALS INCORPORATED 50 Glybera R 50 Visian Toric ICL 50 generic Lipitor 50 Tax Clearance Certificate 50 Cipralex ® 50 TSX PLB 50 drug ISA# 50 HCV genotyping 50 FDA Orphan Drug 50 RoO 50 Hexvix 50 Briyante 50 Solteq Oyj 50 Gleevec Glivec 50 Common Criteria certifications 50 CE Conformite Europeenne 50 Fluarix vaccine 50 GRALISE 50 Rhein Biotech NV 50 incorporate CXA 50 Misonix Announces 50 Rottapharm Madaus 50 OTC IPXL today 50 EASA approvals 50 Ruconest 50 Decree No.# 50 SAFLUTAN 50 TQT study 50 shares issuable pursuant 50 APLAC 50 VivaGel ™ 50 copromotion 50 Silodosin 50 Genesis Bioventures 50 Orphan Therapeutics 50 Tiazac 50 gluteal injection 50 SpeBio joint venture 50 Sonolith i move 50 XIAPEX 50 BioDelivery 50 NOPR 50 solifenacin succinate 50 Shelf Registration 50 Standard QIA 50 vide SRO 50 VIVITROL ® 50 Rule #:#-# e 50 MCET 50 NYSE Amex Listing 50 Rhucin R 50 Approvable letter 50 CBUAE 50 ItN 50 HSR Antitrust Improvements 50 Mangala Aishwariya Saraswati 50 Sumatriptan Succinate Tablets 50 MorphoSys AG FSE MOR 50 Lodotra 50 Elan NanoCrystal 50 Diatos SA 50 Cease Trade Orders 50 OIML 50 Pharmalink AB 50 Citycon Oyj 50 Skin Cholesterol Test 50 Accelerated Share Repurchase 50 Strong Westrex 50 EITE assistance 50 www.accentia.net 50 Impavido R 50 TRIPs Agreement 50 NYSE Amex PTN 50 Product Designation 50 fipamezole 50 Dorel Marcu 50 DBFOT pattern 50 PIA CAR Kalinga 50 Acetavance TM 50 NeuroSTAT ® 50 substitute LOCs 50 Berinert 50 Legal #.# 50 Sublinox 50 Asentar TM 50 AstraZeneca Toprol 50 PayPoint plc 50 QFII license 50 Onko Sure TM 50 Glitnir banki hf 50 Patient Enrolment 50 Competent Authority 50 Firazyr ® 50 UCB Keppra 50 Dermylex TM 50 inspectional observations 50 QRxPharma Limited 50 Grünenthal GmbH 50 CyDex Pharmaceuticals 50 eu domain name 50 Therapeutic Competitors Report 50 CEPO 50 Pöyry PLC 50 promote ceftobiprole 50 Fibrillex TM 50 NADiA ProsVue 50 IND CTA 50 supplemental Biologics License Application 50 Chemicals Agency ECHA 50 Frova ® 50 Orazol 50 CIMYM 50 JBCPL 50 License Option Agreement 50 Binding Offer 50 Dermylex 50 www.option.com 49 Drug Applications sNDAs 49 BCLI 49 Irinotecan Hydrochloride Injection 49 Patents Upheld 49 GeneCards R 49 Protease Inhibitor 49 SR NYSEArca 49 Fenoglide 49 AERx iDMS 49 Cellpep SA 49 Testosterone Gel 49 PROTONIX 49 CBTE 49 Evoltra R 49 Rhucin ® 49 REGENERX BIOPHARMACEUTICALS INC. 49 STRIANT ® 49 Greenshoe option 49 AnorMED expectation 49 MSc Qualified Person 49 MONOVISC 49 A5 Laboratories Inc. 49 sumatriptan DosePro 49 Aurobindo Pharma Limited 49 Enhanced HIPC Initiative 49 Mutual Recognition 49 Qurius NV 49 NeoVisc 49 Embosphere R 49 Teysuno 49 Certificate STC 49 CE IVD 49 Paragraph IV certifications 49 theagreement 49 PrevOnco ™ 49 donepezil hydrochloride 49 VWP travelers 49 MEMO/#/# [002] 49 Glenmark Generics Ltd 49 ACAPODENE R 49 #.# Crores [003] 49 Final Approval 49 ARIXTRA R 49 MTP Ventures 49 PCOP 49 SBL Vaccines 49 phase IIb trial 49 QVAR ® 49 Nascobal 49 trade name Normix 49 Initiates Enrollment 49 HIV integrase inhibitor 49 European Marketing Authorizations 49 MabThera ® 49 therefore therapeutically equivalent 49 valopicitabine NM# 49 MagPotash 49 Terapia Ranbaxy 49 Actimmune R 49 Demonstrates Significant 49 STRIANT R 49 Vernalis plc 49 des Carrieres et 49 END FOOTNOTE 49 earnout provision 49 Positive Opinion 49 Pre IND 49 Eurolist compartment C 49 Zentaris 49 Debt Settlement Agreements 49 Pharmacopeial Convention 49 Celmed 49 Ark. Sup 49 Campto 49 Receives Fast Track 49 EGRIFTA ™ 49 silodosin 49 Andrx Corporation 49 Oracea TM 49 Taglich Brothers Initiates Coverage 49 TSX RBM OTCBB 49 Value Enhancement Plan 49 TSX VENTURE GXG 49 Shonin approval 49 CVac 49 WSPP 49 Psivida 49 severe hypercholesterolemia 49 Lyophilized 49 CLIA certification 49 Ecopetrol SA Ecopetrol 49 Pirespa 49 RIGScan CR 49 Tamsulosin 49 Filgrastim 49 inhaled AAT 49 Sanofi Aventis Allegra 49 mini ratna status 49 CHFY 49 Metvix 49 PPPAC 49 www.systemc.org 49 IDE Investigational Device Exemption 49 Current Controlled Trials 49 Acquisition Transaction 49 Regains NASDAQ 49 SEDAR www.SEDAR.com 49 WILEX 49 Reclast Aclasta 49 #KSB 49 Multiferon 49 trading symbol GCKO 49 Velcade bortezomib 49 PTI LKJ 49 Indusind Bank Ltd 49 Takeda Pharma 49 Teva Provides Update 49 Patent Broadly Covering 49 PCPZ 49 Orosi Mill project 49 Bafna Pharma 49 Biometric Passports 49 Virium 49 Entereg alvimopan 49 tolperisone 49 Q#IR 49 Ravelston Entities 49 vertebral augmentation 49 Shigamabs 49 DJ DGAP IRE 49 Lupin Pharmaceuticals 49 Cellegesic TM nitroglycerin ointment 49 Keppra XR 49 AMEX AKN today 49 GenWay Biotech 49 Intellectual Property Rights TRIPs 49 Metricath Gemini 49 UPLYSO 49 Merck Serono SA 49 VIVIMIND ™ 49 un audited consolidated 49 Accession Agreement 49 Regulatory Approval 49 inter partes reexamination 49 ZEGERID Chewable Tablets 49 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 49 Combunox 49 Promatek 49 TNGS 49 CIPI 49 repurchase authorizations 49 approvable letters 49 BGMO 49 Nasacort 49 MAAs 49 ENLIGHT 49 David W. Gryska 49 www.soliris.net 49 Contingent Value Rights 49 Standardization Administration 49 Competitive Impact Statement 49 Acapodene R 49 PROMACTA CARES 49 SEASONIQUE 49 Remium AB 49 OraTest R 49 share repurchase authorizations 49 Rs.2 #cr 49 VANTAS 49 Submits Investigational 49 MUMBAI Glenmark Pharmaceuticals 49 Biotie 49 ESML Intressenter AB 49 www.vicortech.com 49 Ministerial Decree No. 49 PROCHIEVE 49 AMEX RGN 49 Fast Track designation 49 intravenous AAT 49 Vidaza R 49 http:/www.npsp.com 49 www.adeonapharma.com 49 NDA Submission 49 HTS MTP 49 ZEFTERA TM 49 Loxapine 49 Clinical Trial Data 49 octagam ® 49 Oryx Pharmaceuticals 49 Lambert Eaton Myasthenic 49 Stock Exchange CNSX 49 Sucanon R 49 Double Taxation Agreements 49 ICH guidelines 49 Intercable ICH Inc. 49 Turvatiimi 49 Amlodipine Besylate 49 RECOTHROM R 49 ASRB 49 AB OMXS BINV 49 NCVT 49 NYSE MIM MID 49 MAGE A3 ASCI 49 InStorage REIT Announces 49 Pre Qualification 49 Astellas Deutschland GmbH 49 Fytokem 49 HOW TO ORDER 49 Allowance EUA 49 GPSi Asia 49 OLpur TM H2H 49 Elitek 49 ARIPO 49 pursuant thereto 49 Flexpoint Announces 49 XYZAL 49 Noyem Gold Project 49 Welichem 49 LUMIGAN R 49 HepeX B 49 Confirmatory Order 49 DIP Loan 49 Proxy Forms 49 homotaurine 49 Dr. Damaj 49 Polyphenon ® E 49 FCDs 49 markets HP Acthar 49 Implementing Regulations 49 Revised Guidelines 49 Nitec 49 OTCBB RDIAF announces 49 Retains CCG Investor Relations 49 Registered Trademarks 49 BioGlue Surgical Adhesive 49 Enabler Releases 49 Maple Biosciences 49 Residue Wax 49 Clinical Trials Agreement 49 MorphoSys proprietary 49 Waiver Agreement 49 CollaRx GENTAMICIN SURGICAL IMPLANT 49 Nasdaq Listing Requirements 49 EIA Notification 49 label Lipofen R 49 Premerger Notification 49 Glucomed 49 Placement QIP 49 Fixed Dose Combination 49 Pilanesberg Project 49 Visual Voicemail patents 49 MDxHealth 49 5 lipoxygenase inhibitor 49 LEUKINE 49 Mexinox 49 Allovectin 7 ® 49 transfusional iron overload 49 NQCI 49 Recombinant Human